Sialadenitis Symptoms and Treatment

Total Page：16

File Type：pdf, Size：1020Kb

Sialadenitis Patient Education What is Sialadenitis? Additional Resources Sialadenitis (sy-A-la-den-eye-tis) is a bacterial infection If you have questions or concerns, talk with your that develops in the salivary glands. This condition doctor or nurse. They can provide you with further occurs when the flow of saliva is slowed or stopped and educational materials on the following related topics: bacteria begin to grow. It develops most commonly in • Parotidectomy (surgery to remove the parotid gland) the parotid glands (located in front of the ears) and the • Preventing infection submandibular and sublingual glands (located under the chin). Sialadenitis can happen after receiving • Radiation to the Head and Neck radiation treatment for cancer. • Dysphagia (difficulty swallowing) • Mucositis (inflammation or sores in the mouth) Salivary Glands • Eating well • Nausea and vomiting • Diarrhea • Pain control • Distress Parotid gland Sublingual Submandibular gland gland What Are the Symptoms of Sialadenitis? Sialadenitis causes a painful swelling or lump in the cheek or under the chin. In some cases, pus drains from the salivary ducts into the mouth. If the infection spreads beyond the salivary gland, you may develop a fever and chills. How is Sialadenitis Treated? Treatment for sialadenitis includes the following: • Fluids to make sure your body is well hydrated. In some cases, it may be necessary to receive fluids through a vein (IV). • Antibiotics to cure the infection • Sour candies or gum to stimulate saliva secretion Sialadenitis usually goes away within a week of treatment. If the infection is not successfully treated with these methods, surgery may be needed to drain the gland. If surgery is needed, your health care team will discuss what to expect and possible side effects with you. For more patient education information, call 1-888-424-2100 toll free or go to www.huntsmancancer.org Produced by Huntsman Cancer Institute © 2010 • Approved by PESC August 2010 • Review date August 2013.

Copy Link

Recommended publications

Sjogren's Syndrome an Update on Disease Pathogenesis, Clinical
Clinical Immunology 203 (2019) 81–121 Contents lists available at ScienceDirect Clinical Immunology journal homepage: www.elsevier.com/locate/yclim Review Article Sjogren’s syndrome: An update on disease pathogenesis, clinical T manifestations and treatment ⁎ Frederick B. Vivinoa, , Vatinee Y. Bunyab, Giacomina Massaro-Giordanob, Chadwick R. Johra, Stephanie L. Giattinoa, Annemarie Schorpiona, Brian Shaferb, Ammon Peckc, Kathy Sivilsd, ⁎ Astrid Rasmussend, John A. Chiorinie, Jing Hef, Julian L. Ambrus Jrg, a Penn Sjögren's Center, Penn Presbyterian Medical Center, University of Pennsylvania Perelman School of Medicine, 3737 Market Street, Philadelphia, PA 19104, USA b Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, 51 N. 39th Street, Philadelphia, PA 19104, USA c Department of Infectious Diseases and Immunology, University of Florida College of Veterinary Medicine, PO Box 100125, Gainesville, FL 32610, USA d Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology Program, 825 NE 13th Street, OK 73104, USA e NIH, Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, Building 10, Room 1n113, 10 Center DR Msc 1190, Bethesda, MD 20892-1190, USA f Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing 100044, China g Division of Allergy, Immunology and Rheumatology, SUNY at Buffalo School of Medicine, 100 High Street, Buffalo, NY 14203, USA 1. Introduction/History and lacrimal glands [4,11]. The syndrome is named, however, after an Ophthalmologist from Jonkoping, Sweden, Dr Henrik Sjogren, who in Sjogren’s syndrome (SS) is one of the most common autoimmune 1930 noted a patient with low secretions from the salivary and lacrimal diseases. It may exist as either a primary syndrome or as a secondary glands.
[Show full text]
Parotid Sialolithiasis and Sialadenitis in a 3-Year-Old Child
Ahmad Tarmizi et al. Egyptian Pediatric Association Gazette (2020) 68:29 Egyptian Pediatric https://doi.org/10.1186/s43054-020-00041-z Association Gazette CASE REPORT Open Access Parotid sialolithiasis and sialadenitis in a 3- year-old child: a case report and review of the literature Nur Eliana Ahmad Tarmizi1, Suhana Abdul Rahim2, Avatar Singh Mohan Singh2, Lina Ling Chooi2, Ong Fei Ming2 and Lum Sai Guan1* Abstract Background: Salivary gland calculi are common in adults but rare in the paediatric population. It accounts for only 3% of all cases of sialolithiasis. Parotid ductal calculus is rare as compared to submandibular ductal calculus. Case presentation: A 3-year-old boy presented with acute painful right parotid swelling with pus discharge from the Stensen duct. Computed tomography revealed calculus obstructing the parotid duct causing proximal ductal dilatation and parotid gland and masseter muscle oedema. The child was treated with conservative measures, and subsequently the swelling and calculus resolved. Conclusions: Small parotid duct calculus in children may be successfully treated with conservative measures which obviate the need for surgery. We discuss the management of parotid sialolithiasis in children and conduct literature search on the similar topic. Keywords: Sialolithiasis, Sialadenitis, Salivary calculi, Parotid gland, Salivary ducts, Paediatrics Background performing computed tomography (CT) of the neck. Sialolithiasis is an obstructive disorder of salivary ductal The unusual presentation, CT findings and its subse- system caused by formation of stones within the salivary quent management were discussed. gland or its excretory duct [1]. The resulting salivary flow obstruction leads to salivary ectasia, gland dilatation Case presentation and ascending infection [2].
[Show full text]
Salivary Gland Infections and Salivary Stones (Sialadentis and Sialithiasis)
Salivary Gland Infections and Salivary Stones (Sialadentis and Sialithiasis) What is Sialadenitis and Sialithiasis? Sialdenitis is an infection of the salivary glands that causes painful swelling of the glands that produce saliva, or spit. Bacterial infections, diabetes, tumors or stones in the salivary glands, and tooth problems (poor oral hygiene) may cause a salivary gland infection. The symptoms include pain, swelling, pus in the mouth, neck skin infection. These infections and affect the submandibular gland (below the jaw) or the parotid glands (in front of the ears). The symptoms can be minor and just be a small swelling after meals (symptoms tend to be worse after times of high saliva flow). Rarely, the swelling in the mouth will progress and can cut off your airway and cause you to stop breathing. What Causes Sialadenitis and Sialithiasis When the flow of saliva is blocked by a small stone (salilithiasis) in a salivary gland or when a person is dehydrated, bacteria can build up and cause an infection. A viral infection, such as the mumps, also can cause a salivary gland to get infected and swell. These infections can also be caused by a spread from rotten or decaying teeth. Sometimes there can be a buildup of calcium in the saliva ducts that form into stones. These can easily stop the flow of saliva and cause problems How are these infections and stones treated? Treatment depends on what caused your salivary gland infection. If the infection is caused by bacteria, your doctor may prescribe antibiotics. Home treatment such as drinking fluids, applying warm compresses, and sucking on lemon wedges or sour candy to increase saliva may help to clear the infection quicker.
[Show full text]
Abscesses Apicectomy
BChD, Dip Odont. (Mondchir.) MBChB, MChD (Chir. Max.-Fac.-Med.) Univ. of Pretoria Co Reg: 2012/043819/21 Practice.no: 062 000 012 3323 ABSCESSES WHAT IS A TOOTH ABSCESS? A dental/tooth abscess is a localised acute infection at the base of a tooth, which requires immediate attention from your dentist. They are usually associated with acute pain, swelling and sometimes an unpleasant smell or taste in the mouth. More severe infections cause facial swelling as the bacteria spread to the nearby tissues of the face. This is a very serious condition. Once the swelling begins, it can spread rapidly. The pain is often made worse by drinking hot or cold fluids or biting on hard foods and may spread from the tooth to the ear or jaw on the same side. WHAT CAUSES AN ABSCESS? Damage to the tooth, an untreated cavity, or a gum disease can cause an abscessed tooth. If the cavity isn’t treated, the inside of the tooth can become infected. The bacteria can spread from the tooth to the tissue around and beneath it, creating an abscess. Gum disease causes the gums to pull away from the teeth, leaving pockets. If food builds up in one of these pockets, bacteria can grow, and an abscess may form. An abscess can cause the bone around the tooth to dissolve. WHY CAN'T ANTIBIOTIC TREATMENT ALONE BE USED? Antibiotics will usually help the pain and swelling associated with acute dental infections. However, they are not very good at reaching into abscesses and killing all the bacteria that are present.
[Show full text]
Orofacial Manifestations of COVID-19: a Brief Review of the Published Literature
CRITICAL REVIEW Oral Pathology Orofacial manifestations of COVID-19: a brief review of the published literature Esam HALBOUB(a) Abstract: Coronavirus disease 2019 (COVID-19) has spread Sadeq Ali AL-MAWERI(b) exponentially across the world. The typical manifestations of Rawan Hejji ALANAZI(c) COVID-19 include fever, dry cough, headache and fatigue. However, Nashwan Mohammed QAID(d) atypical presentations of COVID-19 are being increasingly reported. Saleem ABDULRAB(e) Recently, a number of studies have recognized various mucocutaneous manifestations associated with COVID-19. This study sought to (a) Jazan University, College of Dentistry, summarize the available literature and provide an overview of the Department of Maxillofacial Surgery and potential orofacial manifestations of COVID-19. An online literature Diagnostic Sciences, Jazan, Saudi Arabia. search in the PubMed and Scopus databases was conducted to retrieve (b) AlFarabi College of Dentistry and Nursing, the relevant studies published up to July 2020. Original studies Department of Oral Medicine and published in English that reported orofacial manifestations in patients Diagnostic Sciences, Riyadh, Saudi Arabia. with laboratory-confirmed COVID-19 were included; this yielded 16 (c) AlFarabi College of Dentistry and Nursing, articles involving 25 COVID-19-positive patients. The results showed a Department of Oral Medicine and Diagnostic Sciences, Riyadh, Saudi Arabia. marked heterogeneity in COVID-19-associated orofacial manifestations. The most common orofacial manifestations were ulcerative lesions, (d) AlFarabi College of Dentistry and Nursing, Department of Restorative Dental Sciences, vesiculobullous/macular lesions, and acute sialadentitis of the parotid Riyadh, Saudi Arabia. gland (parotitis). In four cases, oral manifestations were the first signs of (e) Primary Health Care Corporation, Madinat COVID-19.
[Show full text]
Oral Manifestations of Systemic Disease Their Clinical Practice
ARTICLE Oral manifestations of systemic disease ©corbac40/iStock/Getty Plus Images S. R. Porter,1 V. Mercadente2 and S. Fedele3 provide a succinct review of oral mucosal and salivary gland disorders that may arise as a consequence of systemic disease. While the majority of disorders of the mouth are centred upon the focus of therapy; and/or 3) the dominant cause of a lessening of the direct action of plaque, the oral tissues can be subject to change affected person’s quality of life. The oral features that an oral healthcare or damage as a consequence of disease that predominantly affects provider may witness will often be dependent upon the nature of other body systems. Such oral manifestations of systemic disease their clinical practice. For example, specialists of paediatric dentistry can be highly variable in both frequency and presentation. As and orthodontics are likely to encounter the oral features of patients lifespan increases and medical care becomes ever more complex with congenital disease while those specialties allied to disease of and effective it is likely that the numbers of individuals with adulthood may see manifestations of infectious, immunologically- oral manifestations of systemic disease will continue to rise. mediated or malignant disease. The present article aims to provide This article provides a succinct review of oral manifestations a succinct review of the oral manifestations of systemic disease of of systemic disease. It focuses upon oral mucosal and salivary patients likely to attend oral medicine services. The review will focus gland disorders that may arise as a consequence of systemic upon disorders affecting the oral mucosa and salivary glands – as disease.
[Show full text]
Head and Neck
DEFINITION OF ANATOMIC SITES WITHIN THE HEAD AND NECK adapted from the Summary Staging Guide 1977 published by the SEER Program, and the AJCC Cancer Staging Manual Fifth Edition published by the American Joint Committee on Cancer Staging. Note: Not all sites in the lip, oral cavity, pharynx and salivary glands are listed below. All sites to which a Summary Stage scheme applies are listed at the begining of the scheme. ORAL CAVITY AND ORAL PHARYNX (in ICD-O-3 sequence) The oral cavity extends from the skin-vermilion junction of the lips to the junction of the hard and soft palate above and to the line of circumvallate papillae below. The oral pharynx (oropharynx) is that portion of the continuity of the pharynx extending from the plane of the inferior surface of the soft palate to the plane of the superior surface of the hyoid bone (or floor of the vallecula) and includes the base of tongue, inferior surface of the soft palate and the uvula, the anterior and posterior tonsillar pillars, the glossotonsillar sulci, the pharyngeal tonsils, and the lateral and posterior walls. The oral cavity and oral pharynx are divided into the following specific areas: LIPS (C00._; vermilion surface, mucosal lip, labial mucosa) upper and lower, form the upper and lower anterior wall of the oral cavity. They consist of an exposed surface of modified epider- mis beginning at the junction of the vermilion border with the skin and including only the vermilion surface or that portion of the lip that comes into contact with the opposing lip.
[Show full text]
For Immediate Release
For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and CEO (Code no.: 4568, First Section, Tokyo, Osaka, and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, General Manager, Corporate Communications Department Telephone: +81-3-6225-1126 http://www.daiichisankyo.com/ Daiichi Sankyo Launches new Cravit® Formulations in Japan TOKYO, Japan (July 7, 2009) – Daiichi Sankyo Company, Limited (TSE: 4568), today launched new formulations of Cravit® (generic name: Levofloxacin Hydrate), a broad-spectrum oral anti-bacterial agent. These formulations are 500mg and 250mg tablets, and a 10% fine granular preparation in Japan. The company obtained manufacturing and marketing approval on April 22. The drug price listing was on June 19. Daiichi Sankyo drew on PK-PD theory (see note below) to develop the once-daily dosage for the 500mg Cravit® tablet. This tablet lifts the maximum blood concentration and is significantly more bactericidal than the 100mg formulation, taken three times daily, suppressing the development of drug-resistant bacteria. The once-daily dosage of the Cravit® 500mg tablet is an approved standard in more than 120 countries and territories. Since its introduction in December 1993 in Japan, Cravit® has gained approval for treating 43 indications and 32 bacteria. This agent continues to offer outstanding efficacy, and has won accolades for its safety profile. Daiichi Sankyo is confident that its concept of a once-daily dosage of a 500mg tablet will win broad acceptance for improved efficacy and a better suppression of strong bacteria. The company will cultivate this product as a worthy contributor to long-term treatment.
[Show full text]
Basic Histology (23 Questions): Oral Histology (16 Questions
Board Question Breakdown (Anatomic Sciences section) The Anatomic Sciences portion of part I of the Dental Board exams consists of 100 test items. They are broken up into the following distribution: Gross Anatomy (50 questions): Head - 28 questions broken down in this fashion: - Oral cavity - 6 questions - Extraoral structures - 12 questions - Osteology - 6 questions - TMJ and muscles of mastication - 4 questions Neck - 5 questions Upper Limb - 3 questions Thoracic cavity - 5 questions Abdominopelvic cavity - 2 questions Neuroanatomy (CNS, ANS +) - 7 questions Basic Histology (23 questions): Ultrastructure (cell organelles) - 4 questions Basic tissues - 4 questions Bone, cartilage & joints - 3 questions Lymphatic & circulatory systems - 3 questions Endocrine system - 2 questions Respiratory system - 1 question Gastrointestinal system - 3 questions Genitouirinary systems - (reproductive & urinary) 2 questions Integument - 1 question Oral Histology (16 questions): Tooth & supporting structures - 9 questions Soft oral tissues (including dentin) - 5 questions Temporomandibular joint - 2 questions Developmental Biology (11 questions): Osteogenesis (bone formation) - 2 questions Tooth development, eruption & movement - 4 questions General embryology - 2 questions 2 National Board Part 1: Review questions for histology/oral histology (Answers follow at the end) 1. Normally most of the circulating white blood cells are a. basophilic leukocytes b. monocytes c. lymphocytes d. eosinophilic leukocytes e. neutrophilic leukocytes 2. Blood platelets are products of a. osteoclasts b. basophils c. red blood cells d. plasma cells e. megakaryocytes 3. Bacteria are frequently ingested by a. neutrophilic leukocytes b. basophilic leukocytes c. mast cells d. small lymphocytes e. fibrocytes 4. It is believed that worn out red cells are normally destroyed in the spleen by a. neutrophils b.
[Show full text]
SUBMANDIBULAR GLAND REMOVAL Post Operative Instructions
SUBMANDIBULAR GLAND REMOVAL Post Operative Instructions Nurse Line (8:30am to 5pm) 937-496-0261 Emergency After Hours Line 937-496-2600 The Surgery Itself Surgery to remove the submandibular gland involves general anesthesia, typically for about two hours. Patients may be quite sedated for several hours after surgery and may remain sleepy for much of the day. Nausea and vomiting are occasionally seen, and usually resolve by the evening of surgery - even without additional medications. Some patients stay overnight in the hospital; other patients can go home the evening of surgery. Some patients will have a drain in place after surgery; this is removed the following day before you go home from the hospital or in the office 1-2 days after surgery. Your Incision Your incision is closed with absorbable sutures and is covered with a small strip of tape or skin glue. You can shower and wash your hair as usual starting 24 hours after your drain is removed. If you did not have a drain in place after surgery, you may shower 24 hours after surgery. You may wash in a bathtub prior to that time if you are careful not to get your neck wet. Use a dab of Bacitracin ointment on your drain site (on one side of your incision, not covered by the tape or glue) before and after showering. Do not soak or scrub the incision. You might notice bruising around your incision or jaw line and slight swelling above the scar when you are upright. In addition, the scar may become pink and hard.
[Show full text]
Salivary Glands;  the Parotid  Submandibular  and Sublingual Functions of Saliva
Lecture series Gastrointestinal tract Professor Shraddha Singh, Department of Physiology, KGMU, Lucknow Various secretions from GIT First secretion from GIT that encounter the food is SALIVARY SECRETIONS What is saliva • Saliva is the mixed glandular secretion which constantly bathes the teeth and the oral mucosa • First secretion encounter the food • It is vital for oral health • It is constituted by the secretions of the three paired major salivary glands; The Parotid Submandibular and Sublingual Functions of saliva 1. Defense: a. Antibacterial b. Antifungal c.Immunological 2. Digestive function: a. Digestive enzymes – ptyalin, lipase b. Formation of bolus c. Taste 3. Protective function: a. Protective coating for hard tissues-teeth b. Protective coating for soft tissues 4. Lubricative function: a.Keeps the oral cavity moist b.Facilitates speech c.Helps in mastication and swallowing 5. Buffering function Salivary glands Structure of Salivary Gland Parotid gland • Parotid is large accounts for 50% secretion of saliva • Situated in front of ear behind the ramus of mandible • Gland drain in to oral cavity opposite to second molar tooth • Secretions are basically serous Submandibular and Sub lingual gland • The submandibular gland is about half the size of the parotid gland • It lies above the mylohyoid in the floor of the mouth. It opens into the floor of the mouth underneath the anterior part of the tongue • The sublingual is the smallest of the paired major salivary glands, being about one fifth the size of the submandibular. • It
[Show full text]
Submandibular Gland Transfer for Prevention of Xerostomia After Radiation Therapy Swallowing Outcomes
ORIGINAL ARTICLE Submandibular Gland Transfer for Prevention of Xerostomia After Radiation Therapy Swallowing Outcomes Jana Rieger, PhD; Hadi Seikaly, MD; Naresh Jha, MBBS; Jeffrey Harris, MD; David Williams, MD; Richard Liu, MD; Tim McGaw, DDS; John Wolfaardt, PhD Objective: To assess swallowing outcomes in patients had preservation of 1 submandibular gland (SJP group) with oropharyngeal carcinoma in relation to the Seikaly- and 11 who did not (control group). Jha procedure for submandibular gland transfer (SJP). The SJP has recently been described as beneficial in the Main Outcome Measures: Quantitative and qualita- prevention of xerostomia induced by radiation therapy tive aspects of swallowing were obtained to determine in patients with head and neck cancer. whether patients in the SJP group performed more op- timally than those in the control group. Design: Inception cohort. Results: Baseline and stimulated salivary flow rates were Setting: University-affiliated primary care center. significantly different between groups. Patients in the SJP group were able to move the bolus through the oral cavity Patients: A phase 2 clinical trial was conducted from and into the pharynx faster than those in the control group. February 1, 1999, through February 28, 2002, to evalu- In addition, patients in the SJP group swallowed less often ate SJP in patients with head and neck cancer. During per bolus than patients in the control group. The com- that period, a consecutive sample of 51 patients who un- plete swallowing sequence was twice as long in controls. derwent surgical resection and reconstruction with a ra- dial forearm free flap for oropharyngeal carcinoma were Conclusions: The SJP for submandibular gland trans- referred for functional assessment of swallowing after fer appears to be beneficial in promoting more time- completion of adjuvant radiation therapy.
[Show full text]